Patents by Inventor Leanda Jane Kindon

Leanda Jane Kindon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-infammatory macrolide
    Patent number: 8227428
    Abstract: The compound 3?-N-demethyl-4?-O-(2-diethylaminoethanoyl)-6-O-methyl-9a-aza-9a-homoerythromycin A, having the Formula (I): or a salt thereof, compositions comprising the compound, its use in the treatment of neutrophil dominated inflammatory diseases, and methods for its preparation.
    Type: Grant
    Filed: January 28, 2010
    Date of Patent: July 24, 2012
    Assignee: Glaxo Group Limited
    Inventors: Caroline Jane Day, Julien Bruno Douillet, Darko Filic, Leanda Jane Kindon, Goran Kragol, Zorica Marusic-Istuk
  • Pyrazolo[3,4-b]pyridine compounds, and their use as PDE4 inhibitors
    Patent number: 8003663
    Abstract: The invention provides N-{[1,6-diethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo [3,4-b]pyridin-5-yl]methyl}-4-({8-[(2-hydroxyethyl) (methyl)amino]octanoyl}amino)benzamide, whose formula is or a salt thereof, such as the monohydrochloride salt thereof. The invention also provides the use of the compound or salt as inhibitors of phosphodiesterase type IV (PDE4) and/or for the treatment and/or prophylaxis of inflammatory and/or allergic diseases such as chronic obstructive pulmonary disease (COPD), asthma, or rhinitis (e.g. allergic and/or non-allergic rhinitis).
    Type: Grant
    Filed: July 31, 2007
    Date of Patent: August 23, 2011
    Assignee: Glaxo Group Limited
    Inventors: David George Allen, Rodger Phillip Barnett, Reshma Manesh Chudasama, Caroline Jane Day, Christopher David Edlin, Leanda Jane Kindon
  • HEMI-FUMARATE SALT OF A 1,3,4-THIADIAZOLYL DERIVATIVE AS MODULATOR OF THE SPHINGOSINE 1-PHOSPHATE RECEPTOR
    Publication number: 20110034524
    Abstract: The invention relates to the compound (2S)-2-amino-2-{5-[4-(octyloxy)-3-(trifluoromethyl)phenyl]-1,3,4-thiadiazol-2-yl}-1-propanol hemi-fumarate, processes for its preparation, pharmaceutical compositions containing them and its use in the treatment of conditions or disorders which are mediated via the S1P1 receptor.
    Type: Application
    Filed: February 3, 2009
    Publication date: February 10, 2011
    Applicant: Glaxo Group Limited
    Inventors: Michael Simon Anson, Caroline Jane Day, Jonathan Paul Graham, Leanda Jane Kindon, Grahame Robert Woollam
  • POLYMORPH FORMS OF (S)-2-((4-BENZOFURANYL)CARBONYLAMINOMETHYL)-1-((4-(2-METHYL-5-(4-FLUOROPHENYL)THIAZOLYL)CARBONYL)PIPERIDINE
    Publication number: 20100286201
    Abstract: New polymorphic forms of (S)-2-((4-benzofuranyl)carbonylamino methyl)-1-((4-(2-methyl-5-(4-fluorophenyl))thiazolyl)carbonyl)piperidine, methods for their preparation and use in medicine.
    Type: Application
    Filed: September 11, 2008
    Publication date: November 11, 2010
    Inventor: Leanda Jane Kindon
  • Anti-Infammatory Macrolide
    Publication number: 20100197623
    Abstract: The compound 3?-N-demethyl-4?-O-(2-diethylaminoethanoyl)-6-O-methyl-9a-aza-9a-homoerythromycin A, having the Formula (I): or a salt thereof, compositions comprising the compound, its use in the treatment of neutrophil dominated inflammatory diseases, and methods for its preparation.
    Type: Application
    Filed: January 28, 2010
    Publication date: August 5, 2010
    Inventors: Caroline Jane Day, Julien Bruno Douillet, Darko Filic, Leanda Jane Kindon, Goran Kragol, Zorica Marusic-Istuk
  • PYRAZOLO (3, 4-B) PYRIDINE DERIVATIVES AS PDE4 INHIBITORS
    Publication number: 20090326003
    Abstract: The present invention provides a compound of formula (I) or a salt thereof (in particular, a pharmaceutically acceptable salt thereof): The invention also provides the use of the compounds or salts as inhibitors of phosphodiesterase type IV (PDE4) for the treatment or prophylaxis of inflammatory or allergic diseases such as chronic obstructive pulmonary disease (COPD), asthma, rhinitis, atopic dermatitis or psoriasis, e.g. in a mammal such as a human.
    Type: Application
    Filed: July 19, 2007
    Publication date: December 31, 2009
    Inventors: David George Allen, Michael Dennis Dowle, Christopher David Edlin, Leanda Jane Kindon
  • PYRAZOLO[3,4-B]PYRIDINE COMPOUNDS, AND THEIR USE AS PDE4 INHIBITORS
    Publication number: 20090325952
    Abstract: The invention provides a compound of formula (I) or a salt thereof: wherein Ar has the sub-formula (x): as defined herein, and the use of the compounds as inhibitors of PDE4.
    Type: Application
    Filed: July 31, 2007
    Publication date: December 31, 2009
    Inventors: David George Allen, Nicola Mary Aston, Rodger Phillip Barnett, Reshma Manesh Chudasama, Caroline Jane Day, Christopher David Edlin, Leanda Jane Kindon, Naimisha Trivedi
  • 2-Substituted 4-Benzylphthalazinone Derivatives as Histamine H1 and H3 Antagonists
    Publication number: 20090105225
    Abstract: The present invention relates to compounds of formula (I), and salts thereof, processes for their preparation, to compositions containing them and to their use in the treatment of various disorders, such as allergic rhinitis.
    Type: Application
    Filed: April 18, 2007
    Publication date: April 23, 2009
    Applicant: GLAXO GROUP LIMITED
    Inventors: Paul Martin Gore, Ashley Paul Hancock, Simon Teanby Hodgson, Leanda Jane Kindon, Panayiotis Alexandrou Procopiou